D-1167-2017 Class II Terminated

Recalled by Pfizer Inc. — New York, NY

Recall Details

Product Type
Drugs
Report Date
September 27, 2017
Initiation Date
August 22, 2017
Termination Date
February 19, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
115,370 vials

Product Description

HYDROmorphone HCl Injection, USP, 2 mg/mL, 1mL Single-use vial, packaged in cartons of 25 vials, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3365-11 (carton) and 0409-3365-01(vial)

Reason for Recall

Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process.

Distribution Pattern

United States Nationwide (including Puerto Rico) and Singapore

Code Information

Lot: 760853A